cro.directory
← Compare landing

Accelera Srl vs Evotec

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/accelera/evotec

CategoryAccelera SrlEvotec
Listed sitecrocro
SummaryEurope-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.Evotec is a life science company pioneering drug discovery and preclinical development. The organization leverages cutting-edge technology, disruptive science, and extensive disease knowledge to accelerate the journey from concept to cure.
Services
  • GLP Toxicology
  • DART (Reproductive & Developmental Toxicology)
  • Safety Pharmacology
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Translational Research
  • Regulatory Affairs
  • Discovery Research
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • Translational Research
Modalities
  • Small Molecule
  • Biologics (Other)
  • Small Molecule
  • Biologics (Other)
Indications
  • Oncology
Data not yet provided.
Locations
  • Headquarters, Milan, Italy
Data not yet provided.
Certifications
  • AAALAC · Identifier: AAALAC accreditation
  • GLP · Identifier: GLP compliance
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.